APAC to Dominate Stem Cell Therapy Market Through 2025
by mack nene TechSci ResearchAPAC to Dominate Stem Cell Therapy Market Through
2025
Growing public awareness related to the therapeutic potency of stem cells to drive the growth of global stem cell therapy market
According to TechSci Research Report, “Global Stem Cell Therapy Market By Type, By
Source of Stem Cells, By Application, By End Users, By Region, Forecast &
Opportunities, 2025”, the global stem cell therapy market is expected to
grow at a formidable rate of around 12% through 2025 on account of increased
awareness about umbilical stem cell, growing demand for regenerative treatment
options, among others. Additionally, rising R&D initiatives to develop
therapeutic options for chronic diseases and increase in the approval for
clinical trials in stem cell research are further expected to spur the market
during forecast years. However, high cost of the procedure can hamper the
growth of market during forecast period. Moreover, regulatory complications and
ethical & moral framework can further restrict the growth of market.
The
global stem cell therapy market is segmented based on type, source of stem
cells, application, end users, company and region. Based on source of stem
cells, the market can be fragmented into adipose tissue, bone marrow, neural,
embryo/cord blood derived, iPSCs and others. The embryo/cord blood derived
segment is expected to dominate the market during forecast years. This can be
ascribed to the higher totipotency and indefinite lifespan of embryonic stem
cells. Based on application, the market can be categorized into
musculoskeletal, wound & injury, cardiovascular disease (CVD), surgery,
acute graft-versus-host disease, drug discovery & development and others.
The musculoskeletal segment is expected to dominate the market during the next
five years owing to the factors such as larger number of commercialized stem
cell therapy products for the treatment of musculoskeletal disorders and the
increasing prevalence of musculoskeletal disorders.
Browse XX market data Tables and XX Figures spread
through XXX Pages and an in-depth TOC on " Global
Stem Cell Therapy Market"
Industry
Players :
Osiris
Therapeutics, Inc., MEDIPOST Co., Ltd., Anterogen Co., Ltd., Pharmicell Co.,
Ltd., Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals Co., Ltd.,
NuVasive, Inc., RTI Surgical, Inc., AlloSource, Thermo Fisher Scientific and
others are some of the leading players operating in global stem cell therapy
market.
“Asia-Pacific is
expected to witness significant growth in stem cell therapy market during the
forecast period owing to the increasing awareness amongst people pertaining to
benefits of advanced stem cell therapies in the region. Additionally, favourable
initiatives undertaken by several organizations are expected to promote
industry players to come up with innovative solutions. For instance, according
to Pharma Focus Asia, members of Asia-Pacific Economic Cooperation collaborated
with Life Sciences Innovation Forum to involve professionals having expertise
in stem cell therapies from academia and research centers to promote developments
in stem cell research. Moreover, vast research studies taking place in
countries such as Singapore and Japan are further expected to propel the market
through 2025.” said Mr. Karan Chechi, Research Director with TechSci Research,
a research based global management consulting firm.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4488
Customers can also request for 10% free
customization on this report.
“Global Stem Cell Therapy Market By Type, By Source
of Stem Cells, By Application, By End Users, By Region, Forecast &
Opportunities, 2025” has evaluated the future growth potential of
global stem cell therapy market and provides statistics & information on
market size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges and opportunities in global stem cell
therapy market.
Global stem cell therapy
market is expected to grow at a formidable rate of around 12% during the
forecast period. The global stem cell therapy market is driven by the growing
popularity and awareness pertaining to the use of stem cells for the prevention
and cure of certain life
threatening diseases. Additionally, increase in number of stem cell
banks and growing investments by the government and private organizations for
the development of stem cell preservation infrastructure is further propelling
the market across the globe.
The global stem cell
therapy market is segmented based on type, source of stem cells,
application, end users, company and region. Based on type, the market can be
categorized into allogeneic, autologous and syngeneic. The allogenic type
segment is expected to register the highest growth during forecast period
attributable to the rising commercialization of allogeneic stem cell therapy
products, wider therapeutic applications of allogeneic stem cells, easy
production scale-up process, growing number of clinical trials related to
allogeneic stem cell therapies, among others. Based on end users, the market
can be bifurcated into hospitals and clinics. The hospitals segment is expected
to dominate the market during the forecast years. This can be accredited to the
rising preference for stem cell therapies offered by hospitals proves
beneficial for the business growth. Hospitals have affiliations with research
laboratories and academic institutes that carry out research activities for
developing stem cell therapies. On introduction and approval of any novel stem
therapy, hospitals implement it immediately.
Regionally, the stem cell
therapy market has been segmented
into various regions namely Asia-Pacific, North America, South America, Europe,
and Middle East & Africa. Among these regions, North America is expected to
dominate the overall stem cell therapy market during the next five years on
account of the increasing number of clinical trials for stem cell-based
products and increasing public-private funding & research grants.
About Us :
TechSci Research is a
research based management consulting firm providing market research and
advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core
values are value, integrity and insight. Led by a team of dynamic industry
experts, TechSci Research provides its customers with high value market research
and advisory services that helps them identify new market opportunities, growth
engines and innovative ways to capture the market share.
Contact
Mr. Ken Mathews
708 Third
Avenue,
Manhattan,
NY,
New York –
10017
Tel:
+1-646-360-1656
Email : sales@techsciresearch.com
Website : https://www.techsciresearch.com/
Sponsor Ads
Created on Feb 28th 2020 07:01. Viewed 340 times.